Dazukibart, a type I interferon inhibitor, reduced dermatomyositis disease severity while maintaining a well-tolerated safety ...

Dermatomyositis and lupus may share symptoms in some cases. Here's what you need to know about these autoimmune conditions.

Dermatomyositis is a rare inflammatory disease ... Hence, Dr Himanshi Chaudhary insisted that early diagnosis and treatment ...

Pharmacologic therapies are the cornerstone of dermatomyositis management, aimed at reducing inflammation, suppressing autoimmunity, and preventing disease progression. Treatment strategies are ...

Achievement of cancer remission was associated with dermatomyositis complete clinical response among patients with cancer-associated DM.

Patients often get better with treatment. But while taking these medications, it's important to be careful to avoid getting ...

Learn about dermatomyositis and the remarkable journey of Audrey Gouskos. Discover how St. Michael's Hospital has provided ...

Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with autoimmune diseases.

Reports Q3 revenue $9.02M, consensus $4.75M. “Roivant has broadened our clinical pipeline with the newly announced trial of brepocitinib in ...

Treatment with dazukibart, a monoclonal antibody targeting interferon beta, yielded a rapid reduction in dermatomyositis disease activity in adults with skin-predominant and muscle-predominant ...